These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 19126254)

  • 1. Constructive Technology Assessment (CTA) as a tool in coverage with evidence development: the case of the 70-gene prognosis signature for breast cancer diagnostics.
    Retèl VP; Bueno-de-Mesquita JM; Hummel MJ; van de Vijver MJ; Douma KF; Karsenberg K; van Dam FS; van Krimpen C; Bellot FE; Roumen RM; Linn SC; van Harten WH
    Int J Technol Assess Health Care; 2009 Jan; 25(1):73-83. PubMed ID: 19126254
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Methodology of constructive technology assessment in health care.
    Douma KF; Karsenberg K; Hummel MJ; Bueno-de-Mesquita JM; van Harten WH
    Int J Technol Assess Health Care; 2007; 23(2):162-8. PubMed ID: 17493301
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Scenario drafting to anticipate future developments in technology assessment.
    Retèl VP; Joore MA; Linn SC; Rutgers EJ; van Harten WH
    BMC Res Notes; 2012 Aug; 5():442. PubMed ID: 22894140
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness analysis and innovation.
    Jena AB; Philipson TJ
    J Health Econ; 2008 Sep; 27(5):1224-36. PubMed ID: 18619695
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Value of research and value of development in early assessments of new medical technologies.
    Retèl VP; Grutters JP; van Harten WH; Joore MA
    Value Health; 2013; 16(5):720-8. PubMed ID: 23947964
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A changing paradigm in the study and adoption of emerging health care technologies: coverage with evidence development.
    Wallner PE; Konski A
    J Am Coll Radiol; 2008 Nov; 5(11):1125-9. PubMed ID: 18954812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Coverage with Evidence Development: applications and issues.
    Trueman P; Grainger DL; Downs KE
    Int J Technol Assess Health Care; 2010 Jan; 26(1):79-85. PubMed ID: 20059784
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current impact of gene technology on healthcare. A map of economic assessments.
    Rogowski W
    Health Policy; 2007 Feb; 80(2):340-57. PubMed ID: 16678930
    [TBL] [Abstract][Full Text] [Related]  

  • 9. American Society of Clinical Oncology guidance statement: the cost of cancer care.
    Meropol NJ; Schrag D; Smith TJ; Mulvey TM; Langdon RM; Blum D; Ubel PA; Schnipper LE;
    J Clin Oncol; 2009 Aug; 27(23):3868-74. PubMed ID: 19581533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conditionally funded field evaluations and practical trial design within a health technology assessment framework.
    Bowen JM; Patterson LL; O'Reilly D; Hopkins RB; Blackhouse G; Burke N; Xie F; Tarride JE; Goeree R
    J Am Coll Radiol; 2009 May; 6(5):324-31. PubMed ID: 19394573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identifying patient-relevant endpoints among individuals with schizophrenia: an application of patient-centered health technology assessment.
    Kinter ET; Schmeding A; Rudolph I; dosReis S; Bridges JF
    Int J Technol Assess Health Care; 2009 Jan; 25(1):35-41. PubMed ID: 19126249
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diffusion and utilization of magnetic resonance imaging in Asia.
    Hutubessy RC; Hanvoravongchai P; Edejer TT;
    Int J Technol Assess Health Care; 2002; 18(3):690-704. PubMed ID: 12391959
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development and implementation of health technology assessment in Argentina: two steps forward and one step back.
    Rubinstein A; Pichon-Riviere A; Augustovski F
    Int J Technol Assess Health Care; 2009 Jul; 25 Suppl 1():260-9. PubMed ID: 19527545
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Review of gene-expression profiling and its clinical use in breast cancer.
    Stadler ZK; Come SE
    Crit Rev Oncol Hematol; 2009 Jan; 69(1):1-11. PubMed ID: 18614375
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Productive innovations in hospitals: an empirical research on the relation between technology and productivity in the Dutch hospital industry.
    Blank JL; Van Hulst BL
    Health Econ; 2009 Jun; 18(6):665-79. PubMed ID: 18702093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. International diffusion of new health technologies: a ten-country analysis of six health technologies.
    Packer C; Simpson S; Stevens A;
    Int J Technol Assess Health Care; 2006; 22(4):419-28. PubMed ID: 16984674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Early phase Technology Assessment of nanotechnology in oncology.
    Retèl VP; Hummel MJ; van Harten WH
    Tumori; 2008; 94(2):284-90. PubMed ID: 18564618
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The impact of technology on health care cost and policy development.
    Wallner PE; Konski A
    Semin Radiat Oncol; 2008 Jul; 18(3):194-200. PubMed ID: 18513629
    [TBL] [Abstract][Full Text] [Related]  

  • 19. To use technology better.
    Garber AM
    Health Aff (Millwood); 2006; 25(2):w51-3. PubMed ID: 16464903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evidence, appropriateness, and technology assessment in cardiology: a case study of computed tomography.
    Redberg RF
    Health Aff (Millwood); 2007; 26(1):86-95. PubMed ID: 17211017
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.